Dimitrios Tzachanis

Title(s)Professor Of Clinical, Medicine
SchoolVc-health Sciences-schools
Address9500 Gilman Drive #
La Jolla CA 92093
vCardDownload vCard

    Collapse Overview 
    Collapse Websites

    Collapse ORNG Applications 
    Collapse Clinical Trials

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help. to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    Altmetrics Details PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Long-term outcomes of patients with large B-cell lymphoma treated with axicabtagene ciloleucel and prophylactic corticosteroids. Bone Marrow Transplant. 2024 Mar; 59(3):366-372. Oluwole OO, Forcade E, Muñoz J, de Guibert S, Vose JM, Bartlett NL, Lin Y, Deol A, McSweeney P, Goy AH, Kersten MJ, Jacobson CA, Farooq U, Minnema MC, Thieblemont C, Timmerman JM, Stiff P, Avivi I, Tzachanis D, Zheng Y, Vardhanabhuti S, Nater J, Shen RR, Miao H, Kim JJ, van Meerten T. PMID: 38177222.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    2. Outcomes of Chimeric Antigen Receptor (CAR) T-Cell Therapy in Patients with Large B-Cell Lymphoma (LBCL): A Single-Institution Experience. Cancers (Basel). 2023 Sep 21; 15(18). Trando A, Ter-Zakarian A, Yeung P, Goodman AM, Hamdan A, Hurley M, Jeong AR, Tzachanis D. PMID: 37760639; PMCID: PMC10527363.
      View in: PubMed   Mentions:
    3. Impact of prior therapies and subsequent transplantation on outcomes in adult patients with relapsed or refractory B-cell acute lymphoblastic leukemia treated with brexucabtagene autoleucel in ZUMA-3. J Immunother Cancer. 2023 08; 11(8). Shah BD, Cassaday RD, Park JH, Houot R, Oluwole OO, Logan AC, Boissel N, Leguay T, Bishop MR, Topp MS, Tzachanis D, O'Dwyer KM, Arellano ML, Lin Y, Baer MR, Schiller GJ, Subklewe M, Abedi M, Minnema MC, Wierda WG, DeAngelo DJ, Stiff PJ, Jeyakumar D, Mao D, Adhikary S, Zhou L, Schuberth PC, Damico Khalid R, Ghobadia A. PMID: 37648261; PMCID: PMC10471850.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    4. NCCN Guidelines® Insights: Hematopoietic Cell Transplantation, Version 3.2022. J Natl Compr Canc Netw. 2023 02; 21(2):108-115. Saad A, Loren A, Bolaños-Meade J, Chen G, Couriel D, Di Stasi A, El-Jawahri A, Elmariah H, Farag S, Gundabolu K, Gutman J, Ho V, Hoeg R, Horwitz M, Hsu J, Kassim A, Kharfan Dabaja M, Magenau J, Martin T, Mielcarek M, Moreira J, Nakamura R, Nieto Y, Ninos C, Oliai C, Patel S, Randolph B, Schroeder M, Tzachanis D, Varshavsky-Yanovsky AN, Vusirikala M, Algieri F, Pluchino LA. PMID: 36791762.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    5. Two-year follow-up of KTE-X19 in patients with relapsed or refractory adult B-cell acute lymphoblastic leukemia in ZUMA-3 and its contextualization with SCHOLAR-3, an external historical control study. J Hematol Oncol. 2022 12 10; 15(1):170. Shah BD, Ghobadi A, Oluwole OO, Logan AC, Boissel N, Cassaday RD, Leguay T, Bishop MR, Topp MS, Tzachanis D, O'Dwyer KM, Arellano ML, Lin Y, Baer MR, Schiller GJ, Park JH, Subklewe M, Abedi M, Minnema MC, Wierda WG, DeAngelo DJ, Stiff P, Jeyakumar D, Dong J, Adhikary S, Zhou L, Schuberth PC, Faghmous I, Masouleh BK, Houot R. PMID: 36494725; PMCID: PMC9734710.
      View in: PubMed   Mentions: 8     Fields:    Translation:Humans
    6. Patient-reported outcomes in ZUMA-7, a phase 3 study of axicabtagene ciloleucel in second-line large B-cell lymphoma. Blood. 2022 11 24; 140(21):2248-2260. Elsawy M, Chavez JC, Avivi I, Larouche JF, Wannesson L, Cwynarski K, Osman K, Davison K, Rudzki JD, Dahiya S, Dorritie K, Jaglowski S, Radford J, Morschhauser F, Cunningham D, Martin Garcia-Sancho A, Tzachanis D, Ulrickson ML, Karmali R, Kekre N, Thieblemont C, Enblad G, Dreger P, Malladi R, Joshi N, Wang WJ, Solem CT, Snider JT, Cheng P, To C, Kersten MJ. PMID: 35839452; PMCID: PMC10653042.
      View in: PubMed   Mentions: 10     Fields:    Translation:HumansCTClinical Trials
    7. Estimation of Kidney Function in Patients With Multiple Myeloma: Implications for Lenalidomide Dosing. Ann Pharmacother. 2023 01; 57(1):29-35. Salama E, Lam S, Gonsalves WI, Tzachanis D, Momper JD, M Saunders I. PMID: 35511200; PMCID: PMC9619254.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    8. Recent Advances in CAR T-Cell Therapy for Patients with Chronic Lymphocytic Leukemia. Cancers (Basel). 2022 Mar 28; 14(7). Heyman BM, Tzachanis D, Kipps TJ. PMID: 35406490; PMCID: PMC8996890.
      View in: PubMed   Mentions: 3  
    9. Assessing CAR T-Cell Therapy Response Using Genome-Wide Sequencing of Cell-Free DNA in Patients With B-Cell Lymphomas. Transplant Cell Ther. 2022 01; 28(1):30.e1-30.e7. Goodman AM, Holden KA, Jeong AR, Kim L, Fitzgerald KD, Almasri E, McLennan G, Eisenberg M, Jahromi AH, Hoh C, Hurley M, Mulroney C, Tzachanis D, Ball ED, Jensen TJ, Kurzrock R. PMID: 34655803.
      View in: PubMed   Mentions: 9     Fields:    Translation:Humans
    10. Safety profile of chloroquine and hydroxychloroquine: a disproportionality analysis of the FDA Adverse Event Reporting System database. Eur Rev Med Pharmacol Sci. 2021 Oct; 25(19):6003-6012. Papazisis G, Siafis S, Cepatyte D, Giannis D, Stamoula E, Tzachanis D, Egberts T. PMID: 34661260.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    11. Prophylactic corticosteroid use in patients receiving axicabtagene ciloleucel for large B-cell lymphoma. Br J Haematol. 2021 08; 194(4):690-700. Oluwole OO, Bouabdallah K, Muñoz J, De Guibert S, Vose JM, Bartlett NL, Lin Y, Deol A, McSweeney PA, Goy AH, Kersten MJ, Jacobson CA, Farooq U, Minnema MC, Thieblemont C, Timmerman JM, Stiff P, Avivi I, Tzachanis D, Kim JJ, Bashir Z, McLeroy J, Zheng Y, Rossi JM, Johnson L, Goyal L, van Meerten T. PMID: 34296427; PMCID: PMC8457222.
      View in: PubMed   Mentions: 55     Fields:    Translation:HumansCTClinical Trials
    12. KTE-X19 for relapsed or refractory adult B-cell acute lymphoblastic leukaemia: phase 2 results of the single-arm, open-label, multicentre ZUMA-3 study. Lancet. 2021 08 07; 398(10299):491-502. Shah BD, Ghobadi A, Oluwole OO, Logan AC, Boissel N, Cassaday RD, Leguay T, Bishop MR, Topp MS, Tzachanis D, O'Dwyer KM, Arellano ML, Lin Y, Baer MR, Schiller GJ, Park JH, Subklewe M, Abedi M, Minnema MC, Wierda WG, DeAngelo DJ, Stiff P, Jeyakumar D, Feng C, Dong J, Shen T, Milletti F, Rossi JM, Vezan R, Masouleh BK, Houot R. PMID: 34097852.
      View in: PubMed   Mentions: 161     Fields:    Translation:HumansCTClinical Trials
    13. In vitro induction of neoantigen-specific T cells in myelodysplastic syndrome, a disease with low mutational burden. Cytotherapy. 2021 04; 23(4):320-328. Ferrari V, Tarke A, Fields H, Ferrari L, Conley T, Ferrari F, Kosaloglu-Yalçin Z, Sette A, Peters B, McCarthy CL, Bashey A, Tzachanis D, Ball ED, Tanaka TN, Bejar R, Lane TA, Vitiello A. PMID: 33262074.
      View in: PubMed   Mentions: 6     Fields:    Translation:HumansCells
    14. Extramedullary early T-cell precursor acute lymphoblastic lymphoma presenting as blast crisis of CML. Blood. 2020 08 27; 136(9):1112. Wang HY, Tzachanis D. PMID: 32853380.
      View in: PubMed   Mentions:    Fields:    Translation:HumansCells
    15. Chronic oral graft-versus-host disease: induction and maintenance therapy with photobiomodulation therapy. Support Care Cancer. 2021 Mar; 29(3):1387-1394. Epstein JB, Raber-Durlacher JE, Epstein GL, Hazenberg MD, Tzachanis D, Spielberger RT. PMID: 32666212.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    16. Local immune cell infiltration in cutaneous acute graft versus host disease. Int J Womens Dermatol. 2020 Sep; 6(4):311-317. Sennett R, Jama BM, Hinds B, Tzachanis D, Morris GP, Marsch AF. PMID: 33015293; PMCID: PMC7522857.
      View in: PubMed   Mentions:
    17. Summary of international recommendations in 23 languages for patients with cancer during the COVID-19 pandemic. Lancet Oncol. 2020 06; 21(6):759-760. Mauri D, Kamposioras K, Tolia M, Alongi F, Tzachanis D, International Oncology Panel and European Cancer Patient Coalition collaborators. PMID: 32410877; PMCID: PMC7220173.
      View in: PubMed   Mentions: 22     Fields:    Translation:HumansCellsPHPublic Health
    18. Hematopoietic Cell Transplantation, Version 2.2020, NCCN Clinical Practice Guidelines in Oncology J Natl Compr Canc Netw. 2020 05 01; 18(5):599-634. Saad A, de Lima M, Anand S, Bhatt VR, Bookout R, Chen G, Couriel D, Di Stasi A, El-Jawahri A, Giralt S, Gutman J, Ho V, Horwitz M, Hsu J, Juckett M, Kharfan-Dabaja MA, Loren A, Meade J, Mielcarek M, Moreira J, Nakamura R, Nieto Y, Roddy J, Satyanarayana G, Schroeder M, Tan CR, Tzachanis D, Burn J, Pluchino L. PMID: 32519831.
      View in: PubMed   Mentions: 20     Fields:    Translation:Humans
    19. Behind the numbers and the panic of a viral pandemic: fixed restrictive oncology guidance may jeopardize patients' survival. J BUON. 2020 May-Jun; 25(3):1277-1280. Mauri D, Tzachanis D, Valachis A, Kamposioras K, Tolia M, Dambrosio M, Zarkavelis G, Gkoura S, Gazouli I, De Lorenzo F, Apostolidis K. PMID: 32862566.
      View in: PubMed   Mentions: 3     Fields:    Translation:HumansPHPublic Health
    20. Patient and family support in the era of fake e-medicine: food for thought from an international consensus panel. ESMO Open. 2020 04; 5(2). Mauri D, Kamposioras K, Tzachanis D, Tolia M, Valachis A, Dambrosio M, Alongi F, De Mello RA, Lövey J, Anthoney A, Christopoulos C, Saraireh HH, Kountourakis P, Kampletsas E, Tsali L, Tsakiridis T, Kosovitsas I, Soukovelos A, Lymperatou D, Polyzos N, Zarkavelis G. PMID: 32340999; PMCID: PMC7204800.
      View in: PubMed   Mentions: Translation:Humans
    21. Intensive Induction Therapy Compared With CHOP for Hepatosplenic T-cell Lymphoma. Clin Lymphoma Myeloma Leuk. 2020 07; 20(7):431-437.e2. Klebaner D, Koura D, Tzachanis D, Ball ED, Horwitz S, Goodman AM. PMID: 32284297.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    22. Reduced-Intensity Conditioning Regimens, Prior Chronic Lymphocytic Leukemia, and Graft-Versus-Host Disease Are Associated with Higher Rates of Skin Cancer after Allogeneic Hematopoietic Stem Cell Transplantation. J Invest Dermatol. 2019 03; 139(3):591-599. Wu PA, Stern RS, Huang V, Liu KX, Chen CA, Tzachanis D, Joyce RM, Davis RB, Ho VT. PMID: 30316899.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    23. Tachyphylaxis to the Sedative Action of Mirtazapine. Am J Case Rep. 2018 Apr 07; 19:410-412. Papazisis G, Siafis S, Tzachanis D. PMID: 29626184; PMCID: PMC5907691.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    24. Phase 1 clinical trial evaluating abatacept in patients with steroid-refractory chronic graft-versus-host disease. Blood. 2018 06 21; 131(25):2836-2845. Nahas MR, Soiffer RJ, Kim HT, Alyea EP, Arnason J, Joyce R, Antin JH, Ho VT, Stroopinsky D, Li S, Levine JD, McMasters M, Jain S, Hamdan A, Tzachanis D, Bryant MP, Logan EK, Bazemore J, Stewart J, Joyce A, Stephenson S, Washington A, Cole L, Pyzer A, Leaf RK, Avigan DE, Rosenblatt J. PMID: 29549175.
      View in: PubMed   Mentions: 15     Fields:    Translation:HumansCellsCTClinical Trials
    25. Antipsychotic Drugs: From Receptor-binding Profiles to Metabolic Side Effects. Curr Neuropharmacol. 2018; 16(8):1210-1223. Siafis S, Tzachanis D, Samara M, Papazisis G. PMID: 28676017; PMCID: PMC6187748.
      View in: PubMed   Mentions: 39     Fields:    Translation:HumansAnimals
    26. Exposure to the drug company marketing in Greece: Interactions and attitudes in a non-regulated environment for medical students. Ann Med Surg (Lond). 2017 Jul; 19:23-28. Filippiadou M, Kouvelas D, Garyfallos G, Tsakiridis I, Tzachanis D, Spachos D, Papazisis G. PMID: 28603612; PMCID: PMC5454084.
      View in: PubMed   Mentions: 1  
    27. Photobiomodulation therapy in the management of chronic oral graft-versus-host disease. Support Care Cancer. 2017 02; 25(2):357-364. Epstein JB, Raber-Durlacher JE, Lill M, Linhares YP, Chang J, Barasch A, Slief RI, Geuke M, Zecha JA, Milstein DM, Tzachanis D. PMID: 27655559.
      View in: PubMed   Mentions: 9     Fields:    Translation:Humans
    28. Erratum to: Complex management of resistant oral herpes simplex virus infection following hematopoietic stem cell transplantation: potential role of topical cidofovir. Support Care Cancer. 2016 Aug; 24(8):3607. Epstein JB, Gharapetian S, Rejali AR, Zabner R, Lill M, Tzachanis D. PMID: 27278274.
      View in: PubMed   Mentions:    Fields:    
    29. CHAMPION-1: a phase 1/2 study of once-weekly carfilzomib and dexamethasone for relapsed or refractory multiple myeloma. Blood. 2016 06 30; 127(26):3360-8. Berenson JR, Cartmell A, Bessudo A, Lyons RM, Harb W, Tzachanis D, Agajanian R, Boccia R, Coleman M, Moss RA, Rifkin RM, Patel P, Dixon S, Ou Y, Anderl J, Aggarwal S, Berdeja JG. PMID: 27207788; PMCID: PMC4929927.
      View in: PubMed   Mentions: 47     Fields:    Translation:HumansCTClinical Trials
    30. Complex management of resistant oral herpes simplex virus infection following hematopoietic stem cell transplantation: potential role of topical cidofovir. Support Care Cancer. 2016 08; 24(8):3603-6. Epstein JB, Gharapetian S, Rejali AR, Zabner R, Lill M, Tzachanis D. PMID: 27165053.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    31. A Case of Subacute Encephalopathy Developing After Treatment With Clofarabine and Methotrexate That Resolved With Corticosteroids. Am J Ther. 2016 May-Jun; 23(3):e937-40. Tzachanis D, Haider M, Papazisis G. PMID: 24987945.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    32. Early diagnosis and successful management of oral mucormycosis in a hematopoietic stem cell transplant recipient: case report and literature review. Support Care Cancer. 2016 08; 24(8):3343-6. Epstein JB, Kupferman SB, Zabner R, Rejali A, Hopp ML, Lill M, Tzachanis D. PMID: 26971955.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    33. Plasmablastic lymphoma is treatable in the HAART era. A 10 year retrospective by the AIDS Malignancy Consortium. Leuk Lymphoma. 2016 07; 57(7):1731-4. Noy A, Lensing SY, Moore PC, Gupta N, Aboulafia D, Ambinder R, Baiocchi R, Dezube BJ, Henry D, Kaplan L, Levine AM, Mitsuyasu R, Ratner L, Reid E, Remick S, Sparano J, Tzachanis D, Wachsman W, Chadburn A. PMID: 26674561; PMCID: PMC4899288.
      View in: PubMed   Mentions: 14     Fields:    Translation:Humans
    34. Yttrium-90 ibritumomab tiuxetan followed by rituximab maintenance as treatment for patients with diffuse large B-cell lymphoma are not candidates for autologous stem cell transplant. Acta Haematol. 2015; 133(4):347-53. Arnason JE, Luptakova K, Rosenblatt J, Tzachanis D, Avigan D, Zwicker JI, Levine J, Kim M, Parker JA, Grant B, Joyce RM. PMID: 25677780.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    35. Primary cardiac burkitt lymphoma presenting with abdominal pain. Case Rep Hematol. 2014; 2014:687598. Tzachanis D, Dewar R, Luptakova K, Chang JD, Joyce RM. PMID: 25431699; PMCID: PMC4241305.
      View in: PubMed   Mentions: 2  
    36. A 78-year-old man with acute myeloid leukemia (AML) and acute renal failure. Am J Case Rep. 2014 Aug 30; 15:364-7. Tapper EB, Luptakova K, Joyce RM, Tzachanis D. PMID: 25184701; PMCID: PMC4159241.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    37. Pregabalin's abuse potential: a mini review focusing on the pharmacological profile. Int J Clin Pharmacol Ther. 2014 Aug; 52(8):709-16. Papazisis G, Tzachanis D. PMID: 24849194.
      View in: PubMed   Mentions: 14     Fields:    Translation:HumansAnimalsCells
    38. Successful treatment of refractory Guillain-Barré syndrome with alemtuzumab in a patient with chronic lymphocytic leukemia. Acta Haematol. 2014; 132(2):240-3. Tzachanis D, Hamdan A, Uhlmann EJ, Joyce RM. PMID: 24853856.
      View in: PubMed   Mentions: 5     Fields:    Translation:HumansCells
    39. Vaccination with dendritic cell/tumor fusions following autologous stem cell transplant induces immunologic and clinical responses in multiple myeloma patients. Clin Cancer Res. 2013 Jul 01; 19(13):3640-8. Rosenblatt J, Avivi I, Vasir B, Uhl L, Munshi NC, Katz T, Dey BR, Somaiya P, Mills H, Campigotto F, Weller E, Joyce R, Levine JD, Tzachanis D, Richardson P, Laubach J, Raje N, Boussiotis V, Yuan YE, Bisharat L, Held V, Rowe J, Anderson K, Kufe D, Avigan D. PMID: 23685836; PMCID: PMC3755905.
      View in: PubMed   Mentions: 98     Fields:    Translation:HumansCellsPHPublic Health
    40. Lenalidomide enhances anti-myeloma cellular immunity. Cancer Immunol Immunother. 2013 Jan; 62(1):39-49. Luptakova K, Rosenblatt J, Glotzbecker B, Mills H, Stroopinsky D, Kufe T, Vasir B, Arnason J, Tzachanis D, Zwicker JI, Joyce RM, Levine JD, Anderson KC, Kufe D, Avigan D. PMID: 22733396; PMCID: PMC4098790.
      View in: PubMed   Mentions: 86     Fields:    Translation:HumansCells
    41. PD-1 blockade by CT-011, anti-PD-1 antibody, enhances ex vivo T-cell responses to autologous dendritic cell/myeloma fusion vaccine. J Immunother. 2011 Jun; 34(5):409-18. Rosenblatt J, Glotzbecker B, Mills H, Vasir B, Tzachanis D, Levine JD, Joyce RM, Wellenstein K, Keefe W, Schickler M, Rotem-Yehudar R, Kufe D, Avigan D. PMID: 21577144; PMCID: PMC3142955.
      View in: PubMed   Mentions: 152     Fields:    Translation:HumansCells
    42. Cancer vaccines in hematologic malignancies: advances, challenges and therapeutic potential. Expert Rev Vaccines. 2010 May; 9(5):451-4. Avigan D, Tzachanis D. PMID: 20450317.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    43. Generation of tumor-specific T lymphocytes using dendritic cell/tumor fusions and anti-CD3/CD28. J Immunother. 2010 Feb-Mar; 33(2):155-66. Rosenblatt J, Wu Z, Vasir B, Zarwan C, Stone R, Mills H, Friedman T, Konstantinopoulos PA, Spentzos D, Ghebremichael M, Stevenson K, Neuberg D, Levine JD, Joyce R, Tzachanis D, Boussiotis V, Kufe D, Avigan D. PMID: 20145548; PMCID: PMC2938173.
      View in: PubMed   Mentions: 15     Fields:    Translation:HumansCells
    44. Immunomodulatory effects of vitamin D: implications for GVHD. Bone Marrow Transplant. 2010 Sep; 45(9):1463-8. Rosenblatt J, Bissonnette A, Ahmad R, Wu Z, Vasir B, Stevenson K, Zarwan C, Keefe W, Glotzbecker B, Mills H, Joyce R, Levine JD, Tzachanis D, Boussiotis V, Kufe D, Avigan D. PMID: 20081878; PMCID: PMC5813246.
      View in: PubMed   Mentions: 15     Fields:    Translation:HumansCells
    45. Tob, a member of the APRO family, regulates immunological quiescence and tumor suppression. Cell Cycle. 2009 Apr 01; 8(7):1019-25. Tzachanis D, Boussiotis VA. PMID: 19270514; PMCID: PMC2908893.
      View in: PubMed   Mentions: 16     Fields:    Translation:HumansAnimalsCells
    46. Weekly docetaxel regimens and radiation pneumonitis. J Support Oncol. 2008 Jul-Aug; 6(6):265-6. Mauri D, Tzachanis D, Tsekoura P, Xanthakis I, Tsali L, Roumbkou S, Fountzilas G. PMID: 18724534.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    47. Neuroprotection by lamotrigine in a rat model of neonatal hypoxic-ischaemic encephalopathy. Int J Neuropsychopharmacol. 2008 May; 11(3):321-9. Papazisis G, Kallaras K, Kaiki-Astara A, Pourzitaki C, Tzachanis D, Dagklis T, Kouvelas D. PMID: 17897482.
      View in: PubMed   Mentions: 12     Fields:    Translation:Animals
    48. Twisted gastrulation (Tsg) is regulated by Tob and enhances TGF-beta signaling in activated T lymphocytes. Blood. 2007 Apr 01; 109(7):2944-52. Tzachanis D, Li L, Lafuente EM, Berezovskaya A, Freeman GJ, Boussiotis VA. PMID: 17164348; PMCID: PMC1852213.
      View in: PubMed   Mentions: 11     Fields:    Translation:HumansCells
    49. Rap1-GTP is a negative regulator of Th cell function and promotes the generation of CD4+CD103+ regulatory T cells in vivo. J Immunol. 2005 Sep 01; 175(5):3133-9. Li L, Greenwald RJ, Lafuente EM, Tzachanis D, Berezovskaya A, Freeman GJ, Sharpe AH, Boussiotis VA. PMID: 16116203.
      View in: PubMed   Mentions: 14     Fields:    Translation:AnimalsCells
    50. Intrinsic and extrinsic regulation of T lymphocyte quiescence. Leuk Lymphoma. 2004 Oct; 45(10):1959-67. Tzachanis D, Lafuente EM, Li L, Boussiotis VA. PMID: 15370239.
      View in: PubMed   Mentions: 27     Fields:    Translation:HumansAnimalsCells
    51. Differential localization and function of ADP-ribosylation factor-6 in anergic human T cells: a potential marker for their identification. J Immunol. 2003 Aug 15; 171(4):1691-6. Tzachanis D, Appleman LJ, Van Puijenbroek AA, Berezovskaya A, Nadler LM, Boussiotis VA. PMID: 12902467.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansCells
    52. Induction of immunologic tolerance for allogeneic hematopoietic cell transplantation. Leuk Lymphoma. 2002 Jun; 43(6):1159-67. Appleman LJ, Tzachanis D, Grader-Beck T, Van Puijenbroek AA, Boussiotis VA. PMID: 12152983.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansAnimalsCells
    53. Tob is a negative regulator of activation that is expressed in anergic and quiescent T cells. Nat Immunol. 2001 Dec; 2(12):1174-82. Tzachanis D, Freeman GJ, Hirano N, van Puijenbroek AA, Delfs MW, Berezovskaya A, Nadler LM, Boussiotis VA. PMID: 11694881.
      View in: PubMed   Mentions: 106     Fields:    Translation:HumansCells
    54. Helper T cell anergy: from biochemistry to cancer pathophysiology and therapeutics. J Mol Med (Berl). 2001; 78(12):673-83. Appleman LJ, Tzachanis D, Grader-Beck T, van Puijenbroek AA, Boussiotis VA. PMID: 11434720.
      View in: PubMed   Mentions: 10     Fields:    Translation:HumansAnimalsCells
    With one click, see people who:

    Mentor Faculty

    Run Clinical Trials

    See more options in the Advanced Search tab

    Dimitrios's Networks
    Concepts (299)
    Derived automatically from this person's publications.
    Explore
    _
    Co-Authors (25)
    People in Profiles who have published with this person.
    Explore
    _
    Similar People (60)
    People who share similar concepts with this person.
    Explore
    _
    Same Department
    Search Department
    _

    UCSD Profiles is managed by the UC San Diego Altman Clinical and Translational Research Institute (ACTRI).
    This site is running Profiles RNS version UCSF-v3.1.0-3-g1ef1264b on PROFILES-PWEB03. We use cookies to operate our website. We also use cookies to analyze our site’s performance and improve your experience on our site. For more information about how we use cookies, please see our Website Terms of Use.

    Copyright © The Regents of the University of California